3
by Clark, Michelle, Featherstone, Robin
Published 2019
CADTH
.... The production of methamphetamine is dangerous and produces large volumes of toxic chemical waste. In 2006...

4
by Clark, Michelle, Featherstone, Robin
Published 2019
CADTH
.... The production of methamphetamine is dangerous and produces large volumes of toxic chemical waste. In 2006...

5
by La Fleur, Philip, Jones, Sarah
Published 2017
Canadian Agency for Drugs and Technologies in Health
... products. These products use antimicrobial agents such as triclosan, chlorhexidine, iodophors or quaternary...

6
by La Fleur, Philip, Jones, Sarah
Published 2017
Canadian Agency for Drugs and Technologies in Health
... products. These products use antimicrobial agents such as triclosan, chlorhexidine, iodophors or quaternary...

7
by Pohar, Ron, McCormack, Suzanne
Published 2019
Canadian Agency for Drugs and Technologies in Health
...The Eczema Society of Canada has a Seal of Acceptance program "where products are reviewed to earn...

8
by Pohar, Ron, McCormack, Suzanne
Published 2019
Canadian Agency for Drugs and Technologies in Health
...The Eczema Society of Canada has a Seal of Acceptance program "where products are reviewed to earn...

9
Published 2015
Canadian Agency for Drugs and Technologies in Health
... associated side effects including drowsiness, dizziness and dry mouth; according to the product monograph...

10
Published 2015
Canadian Agency for Drugs and Technologies in Health
... associated side effects including drowsiness, dizziness and dry mouth; according to the product monograph...

11
by Richardson, Robin, Adcock, Lorna
Published 2018
CADTH
..., administration of blood product) in pre-hospital settings, and to examine clinical guidelines regarding the use...

12
by Seal, Kelsey, Cimon, Karen, Argáez, Charlene
Published 2017
Canadian Agency for Drugs and Technologies in Health

13
by Seal, Kelsey, Cimon, Karen, Argáez, Charlene
Published 2017
Canadian Agency for Drugs and Technologies in Health

14
Published 2015
CADTH Rapid Response Service
... to innovator INX, which could lead to patients being switched between products. The purpose of this report...

15
by Richardson, Robin, Adcock, Lorna
Published 2018
CADTH
..., administration of blood product) in pre-hospital settings, and to examine clinical guidelines regarding the use...

16
Published 2015
CADTH Rapid Response Service
... to innovator INX, which could lead to patients being switched between products. The purpose of this report...

17
by Marchand, Dave K., Young, Calvin, Loshak, Hannah
Published 2019
CADTH
... or combination product of buprenorphine with naloxone (BUP-NAL) formulations for the treatment of OUD....

18
Published 2016
Canadian Agency for Drugs and Technologies in Health

19
by Marchand, Dave K., Young, Calvin, Loshak, Hannah
Published 2019
CADTH
... or combination product of buprenorphine with naloxone (BUP-NAL) formulations for the treatment of OUD....

20
Published 2016
Canadian Agency for Drugs and Technologies in Health